메뉴 건너뛰기




Volumn 148, Issue 5, 2015, Pages 241-245

Checklists for the use of novel oral anticoagulants by the front-line clinician

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; APIXABAN; DABIGATRAN; RIVAROXABAN; WARFARIN;

EID: 84940941606     PISSN: 17151635     EISSN: 1913701X     Source Type: Journal    
DOI: 10.1177/1715163515596758     Document Type: Review
Times cited : (4)

References (12)
  • 1
    • 19344366484 scopus 로고    scopus 로고
    • Systematic overview of warfarin and its drug and food interactions
    • A.M.HolbrookJ.A.PereiraR.Labiris. Systematic overview of warfarin and its drug and food interactions. Arch Intern Med2005;165:1095-106.
    • (2005) Arch Intern Med , vol.165 , pp. 1095-1106
    • Holbrook, A.M.1    Pereira, J.A.2    Labiris, R.3
  • 2
    • 33750004841 scopus 로고    scopus 로고
    • Warfarin: almost 60 years and still causing problems
    • M.PirmohamedWarfarin: almost 60 years and still causing problems. Br J Clin Pharmacol2006;62:209-511.
    • (2006) Br J Clin Pharmacol , vol.62 , pp. 209-511
    • Pirmohamed, M.1
  • 3
    • 85079937100 scopus 로고    scopus 로고
    • February,,. Revised
    • Eliquis Production Monograph, Pfizer Canada Inc, Kirkland, Quebec, and Bristol-Myers Squibb Canada, Montreal Quebec. Revised February20, 2015.
    • (2015)
  • 4
    • 85079984643 scopus 로고    scopus 로고
    • January,,. Revised
    • Pradaxa Production Monograph, Boehringer Ingelheim Canada Ltd, Burlington, Toronto. Revised January7, 2015.
    • (2015)
  • 5
    • 85079998724 scopus 로고    scopus 로고
    • February,,. Revised
    • Xarelto Product Monograph, Bayer Inc, Toronto, Ontario. Revised February20, 2015.
    • (2015)
  • 6
    • 84911447847 scopus 로고    scopus 로고
    • Approach to the new oral anticoagulants in family practice, part 1: comparing the options (clinical review)
    • J.DouketisA.D.BellJ.EikelboomA.LiewApproach to the new oral anticoagulants in family practice, part 1: comparing the options (clinical review). Can Fam Physician2014;60:989-95.
    • (2014) Can Fam Physician , vol.60 , pp. 989-995
    • Douketis, J.1    Bell, A.D.2    Eikelboom, J.3    Liew, A.4
  • 7
    • 84911366554 scopus 로고    scopus 로고
    • Approach to the new oral anticoagulants in family practice, part 2: addressing frequently asked questions (clinical review)
    • J.DouketisA.D.BellJ.EikelboomA.LiewApproach to the new oral anticoagulants in family practice, part 2: addressing frequently asked questions (clinical review). Can Fam Physician2014;60:997-1001.
    • (2014) Can Fam Physician , vol.60 , pp. 997-1001
    • Douketis, J.1    Bell, A.D.2    Eikelboom, J.3    Liew, A.4
  • 8
    • 84893507765 scopus 로고    scopus 로고
    • A practice tool for the new oral anticoagulants
    • A.MassicotteA practice tool for the new oral anticoagulants. Can Pharm J (Ott)2014;147:25-32.
    • (2014) Can Pharm J (Ott) , vol.147 , pp. 25-32
    • Massicotte, A.1
  • 9
    • 32844472355 scopus 로고    scopus 로고
    • Is pulse palpation helpful in detecting atrial fibrillation? A systematic review
    • G.CookeJ.DoustS.SandersIs pulse palpation helpful in detecting atrial fibrillation? A systematic review. J Fam Practice2006;55:130-4.
    • (2006) J Fam Practice , vol.55 , pp. 130-134
    • Cooke, G.1    Doust, J.2    Sanders, S.3
  • 10
    • 84889058769 scopus 로고    scopus 로고
    • Pharmacokinetic and pharmacodynamic drug interactions with new oral anticoagulants: what do they mean for patients with atrial fibrillation?
    • T.HellwigM.GulsethPharmacokinetic and pharmacodynamic drug interactions with new oral anticoagulants: what do they mean for patients with atrial fibrillation?Ann Pharmacother2013;47:1478-87.
    • (2013) Ann Pharmacother , vol.47 , pp. 1478-1487
    • Hellwig, T.1    Gulseth, M.2
  • 11
    • 84919456547 scopus 로고    scopus 로고
    • Observational study of the effects of dabigatran on gastrointestinal symptoms in patients with non-valvular atrial fibrillation
    • T.YamashitaE.WatanabeT.Ikeda. Observational study of the effects of dabigatran on gastrointestinal symptoms in patients with non-valvular atrial fibrillation. J Arrhythmia2014;30:478-84.
    • (2014) J Arrhythmia , vol.30 , pp. 478-484
    • Yamashita, T.1    Watanabe, E.2    Ikeda, T.3
  • 12
    • 84940907442 scopus 로고    scopus 로고
    • Stability of dabigatran etexilate in manufacturer’s blister pack, unit dose packaging, and community pharmacy blister pack
    • E.H.Z.WangJ.L.BoltD.Decarie. Stability of dabigatran etexilate in manufacturer’s blister pack, unit dose packaging, and community pharmacy blister pack. Can J Hosp Pharm2015;68:16-21.
    • (2015) Can J Hosp Pharm , vol.68 , pp. 16-21
    • Wang, E.H.Z.1    Bolt, J.L.2    Decarie, D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.